Alprostadil alfadex - Schwarz Pharma

Drug Profile

Alprostadil alfadex - Schwarz Pharma

Alternative Names: Alprostadil alfadex complex - Schwarz Pharma; Alprostadil-alpha-cyclodextrin; Edex; Prostaglandin E1-α-cyclodextrin complex; Prostandin; Prostavasin; Rigidur®; Sugiran; Vasaprostan; Vasoprost; Viridal

Latest Information Update: 16 Mar 2015

$50 / €47 *
* $ price applies to USA, Canada and Latin America. € price applies to the rest of the world. Final gross prices may vary according to local VAT.

At a glance

  • Originator Ono Pharmaceutical
  • Developer Ono Pharmaceutical; UCB
  • Class Alpha-Cyclodextrins; Erectile dysfunction therapies; Peripheral vasodilators; Prostaglandins
  • Mechanism of Action Prostaglandin E1 agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Erectile dysfunction; Peripheral arterial disorders

Most Recent Events

  • 16 Mar 2015 Launched for Erectile dysfunction (Diagnosis) in Japan (Intracavernous) before March 2015
  • 16 Mar 2015 Launched for Peripheral arterial disorders in Russia, South Korea and China (Intra-arterial) before March 2015
  • 29 Apr 2013 Actient Pharmaceuticals has been acquired by Auxilium Pharmaceuticals
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top